1218994-35-4 Usage
Description
Methyl 2,4,6-trichloronicotinate, also known as 2,4,6-trichloro-3-pyridinecarboxylic acid methyl ester, is a chemical compound with the molecular formula C7H4Cl3NO2. It is a derivative of nicotinic acid and belongs to the class of organic compounds known as pyridinecarboxylic acids and derivatives. This chemical is characterized by its unique structure and properties, making it an important building block in the production of various compounds used in the pharmaceutical and agricultural industries.
Uses
Used in Pharmaceutical Industry:
Methyl 2,4,6-trichloronicotinate is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs. Its unique chemical structure allows for the creation of compounds with potential therapeutic applications.
Used in Agrochemical Industry:
Methyl 2,4,6-trichloronicotinate is used as an intermediate in the synthesis of agrochemicals, specifically in the production of pesticides and other chemical products. Its insecticidal and herbicidal properties make it a valuable component in the formulation of these products, helping to control pests and weeds in agricultural settings.
Used in Chemical Product Formulation:
Methyl 2,4,6-trichloronicotinate is used as a key component in the formulation of various chemical products, leveraging its insecticidal and herbicidal properties to enhance the effectiveness of these products in their respective applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1218994-35-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,8,9,9 and 4 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1218994-35:
(9*1)+(8*2)+(7*1)+(6*8)+(5*9)+(4*9)+(3*4)+(2*3)+(1*5)=184
184 % 10 = 4
So 1218994-35-4 is a valid CAS Registry Number.
1218994-35-4Relevant articles and documents
SMALL MOLECULE BRADYKININ B2 RECEPTOR MODULATORS
-
Page/Page column 41, (2010/04/25)
The present invention is related to a compound of the formula (I): or a pharmacologically acceptable salt, solvate, or hydrate thereof, wherein R1 is: (a), (b), (c), (d), (e), (f), (g), (h), (i), (j), (k), (l), (m), (n), (o), (p), (q), (r), (s); R2 is C1, F, or methoxy; R3 is methyl, methoxy, hydroxymethyl, H, or absent; R4 is methyl, ethyl, HO, H, or absent; A1 is C or N; A2 is C or N; R6 is H or OH; R5 is: (t), (u), (v), (w), (x), (y), (z).
